See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · SLAS2012 1st Annual Conference & Exhibition · San Diego, California · February 4-8, 2012 · Booth 445

Research Area · Pain

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
11093 4-Quinolone-3-Carboxamide Derivative New 1314230-69-7 ≥98% 2012-01-30 133.512958870473 4-quinolone-3-carboxamide-derivative CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 133.512958870473
9000310 8-methyl Nonanoic Acid 5963-14-4 ≥98% 2008-10-10 5.900375690607 8-methyl-nonanoic-acid Isocapric Acid capsaicin intermediate bacteria growth substrate antimicrobial capsicum bacterial bacterium 5.900375690607
10012588 A-803467 944261-79-4 ≥98% 2009-02-14 0.216574585635 a-803467 Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R 0.216574585635
10010118 AM1241 444912-48-5 >97% 2007-08-29 100.855887047268 am1241 CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic 100.855887047268
10707 AM2201 Exclusive 335161-24-5 ≥98% 2011-03-07 122.151931891489 am2201 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM-2201 AM 2201 122.151931891489
10706 AM2201-d5 Exclusive - ≥99% deuterated product 2011-05-16 40.389135663358 am2201-d5 cannabinoids CB1 CB2 receptors pain forensic sciences CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 40.389135663358
9001029 AM2201 N-(4-fluoropentyl) isomer Exclusive New - ≥98% 2011-08-11 77.275968976324 am2201-n-4-fluoropentyl-isomer forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 77.275968976324
10006974 AM630 164178-33-0 ≥98% 2009-02-09 43.386110274010 am630 Iodopravadoline neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors 43.386110274010
10567 AM694 Exclusive 335161-03-0 ≥95% 2011-01-31 49.851517370280 am694 cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 49.851517370280
13823 AX 048 Exclusive 873079-69-7 ≥98% 2010-09-15 9.311602209945 ax-048 Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids 9.311602209945
10010088 CAY10526 Exclusive 938069-71-7 >98% 2007-09-07 354.735524861878 cay10526 mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions 354.735524861878
10012565 CAY10568 22913-17-3 ≥98% 2008-05-28 4.359401473296 cay10568 Santinamide TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 4.359401473296
10010032 CAY10570 Exclusive 875014-22-5 >98% 2008-06-03 15.524157458564 cay10570 FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids 15.524157458564
13164 CAY10589 Exclusive 1077626-52-8 ≥98% 2009-06-23 1.599972375690 cay10589 Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling 1.599972375690
10820 CAY10651 Exclusive - ≥98% 2011-06-15 0.911602209945 cay10651 Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS 0.911602209945
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 28.189119272017 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 28.189119272017
13289 CB-86 Exclusive 1150586-64-3 ≥98% 2010-05-03 17.418531965272 cb-86 cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 6-Azauridine 6 Azauridine Azauridine cannabinoids cbs synthetic 17.418531965272
10917 (−)-CP 47, 497 114753-51-4 ≥98% 2011-05-05 14.601022069934 -cp-47-497 cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 13218 14.601022069934
10910 (+)-CP 47,497 134308-14-8 ≥98% 2011-05-05 14.120359086509 -cp-47-497 cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 14.120359086509
10913 (±)-CP 47,497 70434-82-1 ≥98% 2011-05-05 28.584859332273 -cp-47-497 receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 28.584859332273
10908 (±)-CP 47,497-C8-homolog Exclusive 70434-92-3 ≥98% 2011-05-06 31.266546931812 -cp-47-497-c8-homolog CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 31.266546931812
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated product 2011-03-14 22.137993152601 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 22.137993152601
13216 (±)-CP 47,497-C8-homolog (solution) Exclusive 70434-92-3 ≥98% 2009-04-23 42.805855529827 -cp-47-497-c8-homolog-solution CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 42.805855529827
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated product 2011-02-16 22.227288860387 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 22.227288860387
13218 (−)-CP 47,497 (solution) 114753-51-4 ≥98% 2009-04-13 16.186230525792 -cp-47-497-solution cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects cannabinoids cbs synthetic 10917 16.186230525792
13219 (+)-CP 47,497 (solution) 134308-14-8 ≥98% 2009-04-13 16.029525352512 -cp-47-497-solution cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 16.029525352512
16851 (±)-CP 47,497 (solution) 70434-82-1 ≥98% 2008-12-10 39.558305947522 -cp-47-497-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 39.558305947522
13608 (+)-CP 55,940 Exclusive - ≥98% 2010-05-20 15.606765830854 -cp-55-940 Δ9-THC cannabinoids CB1 CB2 pain analgesic cannabinoids cbs synthetic 15.606765830854
13241 (±)-CP 55,940 Exclusive 83003-12-7 ≥98% 2009-05-20 23.683423368119 -cp-55-940 cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic 23.683423368119
9000639 Docosahexaenoyl Serotonin Exclusive 283601-58-1 ≥98% 2010-05-18 5.499368587214 docosahexaenoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA L-alpha-Glycerylphosphorylcholine L alpha Glycerylphosphorylcholine Glycerophospholipids Choline Choline Glycerophospholipids Phosphoglycerides Choline 3-Phosphocholine Glycerol Glycerylphosphorylcholine Glycerophosphate Choline Glycerol 3-Phosphocholine Glycerol 3 Phosphocholine Choline Phosphoglycerides Glycerophosphorylcholine Choline Glycerophosphate Alphoscerate Choline Phosphatidylcholines Choline Alphoscerate Alfoscerate Choline Phosphatidylcholine Choline Alfoscerate 5.499368587214
9000640 Eicosapentaenoyl Serotonin Exclusive 199875-71-3 ≥98% 2010-09-10 1.115548539858 eicosapentaenoyl-serotonin N-arachidonoyl serotonins AA-5-HT AA5HT AA 5 HT AA-5HT AA5HT antagonists fatty acids Amide hydrolase FAAH transient receptors potential vanilloid type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Triacylglycerols Triacylglycerol Triglycerides 1.115548539858
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 22.969714548802 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 22.969714548802
10010183 Fatty Acid Amide Hydrolase (human recombinant) - Whole-cell lysate 2008-11-05 30.290694554065 fatty-acid-amide-hydrolase-human-recombinant FAAH (human recombinant) FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases 30.290694554065
10010182 Fatty Acid Amide Hydrolase Western Ready Control - 66 kDa (His-tagged), 63 kDa (native) 2007-07-06 5.941629834254 fatty-acid-amide-hydrolase-western-ready-control Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors 5.941629834254
10011347 Glycerophospho-N-Arachidonoyl Ethanolamine Exclusive 201738-25-2 ≥97% 2009-03-13 13.043020257826 glycerophospho-n-arachidonoyl-ethanolamine Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic 13.043020257826
10224 GPR55 Polyclonal Antibody - 2010-01-19 37.824479084451 gpr55-polyclonal-antibody G Protein-Coupled Receptor 55 proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic 37.824479084451
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 35.513204419889 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 35.513204419889
10010410 GW 848687X 612831-24-0 ≥98% 2009-11-25 15.197071823204 gw-848687x Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X 15.197071823204
10011038 Hemopressin - 2009-08-13 34.124206787687 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 34.124206787687
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 145.000000000000 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 145.000000000000
10215 IDFP 615250-02-7 ≥98% 2009-03-09 17.776906077347 idfp Isopropyl Dodecylfluorophosphonate CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitors cannabinoids 17.776906077347
10266 JWH 007 Exclusive 155471-10-6 ≥98% 2011-02-23 41.855183696024 jwh-007 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 41.855183696024
10486 JWH 007-d9 - ≥99% deuterated product 2010-10-11 41.767284959039 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 41.767284959039
10900 JWH 018 209414-07-3 ≥98% 2011-05-05 39.577776348503 jwh-018 cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 39.577776348503
9000844 JWH 018 2-hydroxyindole metabolite Exclusive - ≥98% 2010-10-26 33.195561139134 jwh-018-2-hydroxyindole-metabolite cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 33.195561139134
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-02-25 26.694531885011 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 26.694531885011
9000851 JWH 018 4-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 48.445014175612 jwh-018-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 48.445014175612
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-02-25 35.432615115512 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 35.432615115512
9000852 JWH 018 5-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 70.917166128041 jwh-018-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 70.917166128041
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-03-11 29.593256865480 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.593256865480
9000853 JWH 018 6-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 44.824529687725 jwh-018-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 44.824529687725
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-03-25 49.836622685829 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 49.836622685829
10697 JWH 018 6-methoxyindole analog Exclusive - ≥98% 2011-02-15 31.143964791342 jwh-018-6-methoxyindole-analog analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 31.143964791342
9000854 JWH 018 7-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 38.913192913297 jwh-018-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 38.913192913297
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-07-26 31.880724826532 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 31.880724826532
13824 JWH 018-d9 (solution) - ≥99% deuterated product 2010-06-21 52.026849569761 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 52.026849569761
10690 JWH 018 N-(2-methylbutyl) isomer Exclusive - ≥97% 2011-03-16 23.834551709417 jwh-018-n-2-methylbutyl-isomer JWH 073 2-methylbutyl homolog cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 23.834551709417
10691 JWH 018 N-(3-methylbutyl) isomer Exclusive - ≥97% 2011-02-07 25.615217461385 jwh-018-n-3-methylbutyl-isomer JWH 073 3-methylbutyl homolog cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 25.615217461385
9000855 JWH 018 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% 2010-09-01 110.725207195855 jwh-018-n-5-hydroxypentyl-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 110.725207195855
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated product 2011-06-22 84.280969004927 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 84.280969004927
9000856 JWH 018 N-pentanoic acid metabolite Exclusive - ≥95% 2010-09-01 113.191739416687 jwh-018-n-pentanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 113.191739416687
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated product 2010-09-15 285.527347157578 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 285.527347157578
13169 JWH 018 (solution) 209414-07-3 ≥98% 2009-03-12 61.536164283319 jwh-018-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 61.536164283319
13633 JWH 019 209414-08-4 ≥98% 2010-01-14 47.701006915275 jwh-019 cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 47.701006915275
10904 JWH 073 208987-48-8 ≥97% 2011-05-06 39.366903671030 jwh-073 cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 39.366903671030
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-10 22.655769438131 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 22.655769438131
9000861 JWH 073 4-hydroxyindole metabolite - ≥98% 2010-09-01 45.894156817418 jwh-073-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 45.894156817418
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-02-21 23.006414005350 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 23.006414005350
9000862 JWH 073 5-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 39.413054888215 jwh-073-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 39.413054888215
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-11 24.793593985438 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 24.793593985438
9000863 JWH 073 6-hydroxyindole metabolite Exclusive - ≥95% 2010-09-01 35.506681622321 jwh-073-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 35.506681622321
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-11 22.655769438131 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 22.655769438131
9000864 JWH 073 7-hydroxyindole metabolite Exclusive - 98% 2010-09-01 32.872977498763 jwh-073-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 32.872977498763
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-07-25 31.304416221317 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 31.304416221317
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated product 2010-08-10 36.372983706442 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 36.372983706442
10927 (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated product 2011-07-25 53.281537154404 -jwh-073-n-3-hydroxybutyl-metabolite-d5 deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience 53.281537154404
9000865 JWH 073 N-(4-hydroxybutyl) metabolite Exclusive - ≥98% 2010-09-01 80.693088252105 jwh-073-n-4-hydroxybutyl-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 80.693088252105
10934 JWH 073 N-(4-hydroxybutyl) metabolite-d5 Exclusive New - ≥99% deuterated product 2011-10-14 69.626629047029 jwh-073-n-4-hydroxybutyl-metabolite-d5 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices 69.626629047029
9000866 JWH 073 N-butanoic acid metabolite Exclusive - ≥98% 2010-09-01 97.480502899403 jwh-073-n-butanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 97.480502899403
9000870 JWH 073 N-butanoic acid metabolite-d5 Exclusive - ≥99% deuterated product 2010-09-20 90.448586063624 jwh-073-n-butanoic-acid-metabolite-d5 JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 90.448586063624
13170 JWH 073 (solution) 208987-48-8 ≥97% 2009-03-02 42.081760843520 jwh-073-solution cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 42.081760843520
10579 JWH 081 210179-46-7 ≥98% 2010-10-22 78.132789745894 jwh-081 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 78.132789745894
10511 JWH 081-d9 New - ≥99% deuterated product 2011-09-08 74.060269253484 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 74.060269253484
10680 JWH 098 Exclusive 316189-74-9 ≥98% 2011-04-20 48.371145627585 jwh-098 JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles 48.371145627585
10591 JWH 122 619294-47-2 ≥98% 2010-12-15 84.926694506780 jwh-122 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs 1 2 CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids cbs synthetic 84.926694506780
10512 JWH 122-d9 New - ≥99% deuterated product 2011-09-08 43.739074134946 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 43.739074134946
10721 JWH 201 Exclusive 864445-47-6 ≥98% 2011-02-24 74.679695533405 jwh-201 cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 74.679695533405
9000736 JWH 203 864445-54-5 ≥98% 2011-02-21 72.826598537970 jwh-203 cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic 72.826598537970
10644 JWH 210 824959-81-1 ≥98% 2011-02-01 124.182033589697 jwh-210 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 124.182033589697
10510 JWH 210-d9 New - ≥99% deuterated product 2011-09-08 60.606560288787 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 60.606560288787
13634 JWH 250 864445-43-2 ≥98% 2010-01-14 76.303045542067 jwh-250 cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic 76.303045542067
10661 JWH 250-d5 Exclusive - ≥99% deuterated product 2011-02-14 32.612719565631 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 32.612719565631
10578 JWH 251 864445-39-6 ≥98% 2010-08-20 50.885617800217 jwh-251 cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic 50.885617800217
10722 JWH 302 Exclusive 864445-45-4 ≥95% 2011-03-04 75.545636592272 jwh-302 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding 75.545636592272
13636 JWH 398 Exclusive - ≥95% 2010-10-22 75.650154835222 jwh-398 jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic 75.650154835222
13158 JZL 184 1101854-58-3 ≥97% 2009-01-26 155.613245856354 jzl-184 2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids 155.613245856354
13668 JZL 195 - ≥98% 2010-02-10 96.011541436463 jzl-195 fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes 1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles 96.011541436463
9001148 Ketorolac New 74103-06-3 ≥98% 2012-01-12 119.952500066725 ketorolac Sprix®; Acular PF®; RS 37619; Acular LS® analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 ± (±) 119.952500066725
10009280 L-759,633 174627-50-0 >98% 2007-09-13 34.822541436464 l-759-633 L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic 34.822541436464
10007712 L-902,688 Exclusive 634193-54-7 ≥98% 2010-05-07 41.522896606156 l-902-688 PGE2 bones growth EP4 agonists hyperalgesia vasodialation 41.522896606156
13453 LH 21 611207-11-5 ≥98% 2011-03-22 16.147578268876 lh-21 cannabimimetic CBs cannabinoids CB1 receptors antagonists pain weight gain obesity LH-21 LH21 central 16.147578268876
9000326 Linoleoyl Glycine 2764-03-6 ≥98% 2008-10-29 5.741560773481 linoleoyl-glycine N-Linoleoyl Glycine; LinGly; Glycine Linoleamide arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs 5.741560773481
10563 MDA 19 1048973-47-2 ≥95% 2010-09-17 50.279857932123 mda-19 agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor 50.279857932123
10639 MDA 77 Exclusive 1103774-21-5 ≥98% 2011-05-16 4.063591160221 mda-77 CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay 4.063591160221
10007812 Monoacylglycerol Lipase (human recombinant) - >95% 2008-04-01 63.794516574585 monoacylglycerol-lipase-human-recombinant MAGL; MGL neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant 63.794516574585
10009566 Monoacylglycerol Lipase Western Ready Control - Whole cell lysate 2007-01-31 11.230307813733 monoacylglycerol-lipase-western-ready-control MGL; MAGL hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry 11.230307813733
10004184 NESS 0327 Exclusive 494844-07-4 >98% 2008-05-27 39.792390758413 ness-0327 neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity 39.792390758413
10007697 N-Palmitoyl Dopamine 136181-87-8 >98% 2005-11-23 5.439668508288 n-palmitoyl-dopamine PALDA N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic 5.439668508288
10009020 N-Palmitoyl Glycine 2441-41-0 ≥98% 2009-12-01 10.384889502762 n-palmitoyl-glycine N-Hexadecanoyl-Glycine; PalGly pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines 10.384889502762
10009195 O-2545 (hydrochloride) - >98% 2007-07-12 1.533701657459 o-2545-hydrochloride cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic 1.533701657459
10010547 O-Arachidonoyl Glycidol Exclusive 439146-24-4 >98% 2008-03-31 18.845900552486 o-arachidonoyl-glycidol 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids 18.845900552486
9000629 Oleoyl Serotonin Exclusive 1002100-44-8 ≥98% 2010-05-18 5.718153117601 oleoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Long-Chain Fatty-Acyl-CoA Fatty-Acyl-CoA Hydrolase Long-Chain Long-Chain Fatty-Acyl-CoA Hydrolase Long Chain Fatty Acyl CoA Hydrolase Palmitoyl Coenzyme A Hydrolase Acylhydrolase Oleoyl-CoA Thioesterase Fatty Acyl Oleoyl-CoA Acylhydrolase Oleoyl CoA Acylhydrolase Hydrolase Palmitoyl-CoA Deacylase, Palmitoyl CoA CoA Deacylase, Palmitoyl Thioesterase, Palmitoyl Palmitoyl-CoA Hydrolase Palmitoyl CoA Hydrolase Palmitoyl CoA Deacylase Hydrolase Stearoyl CoA Fatty Acyl Thioesterase CoA Hydrolase Stearoyl Stearoyl CoA Hydrolase Palmitoyl Thioesterase Hydrolase Acyl CoA CoA Hydrolase Acyl Acyl CoA Hydrolase Thioesterase I 5.718153117601
9000694 Oleoyl Serotonin-d17 Exclusive - ≥99% deuterated product 2010-09-27 5.499368587214 oleoyl-serotonin-d17 N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA deuterateds deuteriums MS mass spectrometry GC-MS LC-MS GC/MS LC/MS standards 5.499368587214
14070 ONO-8711 216158-34-8 ≥98% 2011-06-15 20.194171270718 ono-8711 ONO 8711 ONO8711 prostaglandins EPs EP1 receptors potent PGs antagonists AH-6809 AH 6809 AH6809 14060 14050 SC-19220 SC19220 SC 19220 20.194171270718
9000630 Palmitoyl Serotonin Exclusive 212707-51-2 ≥98% 2010-05-18 5.850749802683 palmitoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Long-Chain Fatty-Acyl-CoA Fatty-Acyl-CoA Hydrolase Long-Chain Long-Chain Fatty-Acyl-CoA Hydrolase Long Chain Fatty Acyl CoA Hydrolase Palmitoyl Coenzyme A Hydrolase Acylhydrolase Oleoyl-CoA Thioesterase Fatty Acyl Oleoyl-CoA Acylhydrolase Oleoyl CoA Acylhydrolase Hydrolase Palmitoyl-CoA Deacylase Palmitoyl CoA CoA Deacylase Palmitoyl Thioesterase Palmitoyl Palmitoyl-CoA Hydrolase Palmitoyl CoA Hydrolase Palmitoyl CoA Deacylase Hydrolase Stearoyl CoA Fatty Acyl Thioesterase CoA Hydrolase Stearoyl Stearoyl CoA Hydrolase Palmitoyl Thioesterase Hydrolase Acyl CoA CoA Hydrolase Acyl Acyl CoA Hydrolase Thioesterase I 5.850749802683
13279 PF-3845 1196109-52-0 ≥98% 2010-01-27 37.140079803560 pf-3845 fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal Monoclonal Antibodies 37.140079803560
10010907 PF-622 898235-65-9 >98% 2008-03-26 10.122044198895 pf-622 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry 10.122044198895
10010908 PF-750 959151-50-9 >98% 2008-03-25 14.324050414364 pf-750 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry 14.324050414364
13368 Piroxicam 36322-90-4 ≥95% 2010-01-06 19.599678383644 piroxicam NSC 666076; Larapam; Feldene inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 19.599678383644
10006973 Pravadoline 92623-83-1 ≥98% 2011-02-08 53.944502841132 pravadoline WIN 48,098 Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 53.944502841132
13621 Pristimerin Exclusive 1258-84-0 ≥98% 2010-03-08 43.218184688240 pristimerin Celastrol methyl ester; NSC 99281 monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes 43.218184688240
10007684 Prostaglandin D Synthase (lipocalin-type; human) EIA Kit Exclusive - 2008-06-09 18.813434622467 prostaglandin-d-synthase-lipocalin-type-human-eia-kit Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays 18.813434622467
10384 Prostaglandin E2 isopropyl ester Exclusive 71845-66-4 ≥98% 2010-06-07 323.110734017363 prostaglandin-e2-isopropyl-ester PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic 323.110734017363
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 24.408416206262 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 24.408416206262
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.333570441988 prostaglandin-e-synthase-1-microsomal-western-ready-control mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.333570441988
10011032 QX-314 (bromide) 24003-58-5 ≥98% 2009-02-03 0.216574585635 qx-314-bromide lidocaine local anesthetic TRPV1 sodium channel blocker pain nociceptor capsaicin 0.216574585635
10491 (R)-AM1241 Exclusive 444912-51-0 ≥98% 2010-05-27 35.049021310181 -r-am1241 (+)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs 35.049021310181
10645 RCS-4 - ≥98% 2010-11-24 131.430540262970 rcs-4 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic 131.430540262970
10513 RCS-4-d9 Exclusive New - ≥99% deuterated product 2011-09-12 45.963138869484 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 45.963138869484
10636 RCS-8 Exclusive - ≥98% 2010-11-02 113.831943745493 rcs-8 SR-18 cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance A2 Thromboxane Thromboxane A2 113.831943745493
10490 (S)-AM1241 Exclusive 444912-53-2 ≥98% 2010-05-27 35.845660176295 -s-am1241 (-)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs 35.845660176295
11019 SB 366791 New 472981-92-3 ≥98% 2011-10-13 5.319407773577 sb-366791 pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 5.319407773577
10011561 SC-51089 146033-02-5 ≥95% 2010-02-02 7.628232044198 sc-51089 CID132748 prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs Oxazepines 7.628232044198
10010744 SC-51322 146032-79-3 >98% 2010-03-09 14.171624309391 sc-51322 SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos 14.171624309391
10012555 Sodium Hydrogen Sulfide (hydrate) 207683-19-0 ≥65% 2009-09-03 27.867152308846 sodium-hydrogen-sulfide-hydrate Sodium Hydrosulfide; NSC 158264; NaHS hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 27.867152308846
9000491 SR 144528 192703-06-3 ≥98% 2009-08-05 73.523807550644 sr-144528 antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic 73.523807550644
9000631 Stearoyl Serotonin Exclusive 67964-87-8 ≥98% 2010-05-18 5.675059194949 stearoyl-serotonin N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA Hydrolase Desaturase Stearoyl-CoA Stearoyl-CoA Desaturase Stearoyl CoA Desaturase Desaturase Stearyl-CoA Stearyl-CoA Desaturase Stearyl CoA Desaturase Desaturase Stearate Stearate Desaturase Desaturase delta-9 delta-9 Desaturase 5.675059194949
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 38.108217181996 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 38.108217181996
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 40.257280540208 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 40.257280540208
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 108.871623695518 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 108.871623695518
10674 URB937 Exclusive - ≥98% 2011-03-08 17.270469613259 urb937 FAAH anandamide AEA inhibitors peripheral pain Cannabinoids 17.270469613259
10736 (±)WIN 55212 (mesylate) New 137795-17-6 ≥98% 2012-01-11 122.540572595838 -win-55212-mesylate cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral 122.540572595838
13665 YS121 Exclusive 916482-17-2 ≥98% 2010-04-02 20.386180939226 ys121 Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 20.386180939226
13271 ZLJ-6 Exclusive 1051931-39-5 ≥98% 2009-06-17 38.592334254143 zlj-6 inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 38.592334254143
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?